IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Uspehi Molekularnoj Onkologii- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

0.35

h-Index

 1

Rank

 23905

SJR

 0.115

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Uspehi Molekularnoj Onkologii
Publication Type Journal
Subject Area, Categories, Scope Biochemistry (medical) (Q4); Cancer Research (Q4); Genetics (clinical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
h-index 1
Overall Rank/Ranking 23905
SCImago Journal Rank (SJR) 0.115
Impact Score 0.35
Publisher ABC-press Publishing House
Country Russian Federation
ISSN 2313805X, 24133787




About Uspehi Molekularnoj Onkologii


Uspehi Molekularnoj Onkologii is a journal covering the technologies/fields/categories related to Biochemistry (medical) (Q4); Cancer Research (Q4); Genetics (clinical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4). It is published by ABC-press Publishing House. The overall rank of Uspehi Molekularnoj Onkologii is 23905. According to SCImago Journal Rank (SJR), this journal is ranked 0.115. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 1. The best quartile for this journal is Q4.

The ISSN of Uspehi Molekularnoj Onkologii journal is 2313805X, 24133787. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Uspehi Molekularnoj Onkologii is cited by a total of 8 articles during the last 3 years (Preceding 2021).


Uspehi Molekularnoj Onkologii Impact Score 2021-2022


The impact score (IS) 2021 of Uspehi Molekularnoj Onkologii is 0.35, which is computed in 2022 as per its definition. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Uspehi Molekularnoj Onkologii Impact Score 2022 Prediction


IS 2021 of Uspehi Molekularnoj Onkologii is 0.35. If the same upward trend persists, impact score may rise in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Uspehi Molekularnoj Onkologii. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 0.35
2020 ''
2019 ''
2018 ''
2017 ''
2016 ''
2015 ''
2014 ''

Uspehi Molekularnoj Onkologii h-index


  Table Setting

Uspehi Molekularnoj Onkologii has an h-index of 1. It means 1 articles of this journal have more than 1 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Uspehi Molekularnoj Onkologii ISSN


The ISSN of Uspehi Molekularnoj Onkologii is 2313805X, 24133787. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Uspehi Molekularnoj Onkologii Rank and SCImago Journal Rank (SJR)


The overall rank of Uspehi Molekularnoj Onkologii is 23905. According to SCImago Journal Rank (SJR), this journal is ranked 0.115. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Uspehi Molekularnoj Onkologii Publisher


Table Setting

Uspehi Molekularnoj Onkologii is published by ABC-press Publishing House. It's publishing house is located in Russian Federation. Coverage history of this journal is as following: 2019-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


How to publish in Uspehi Molekularnoj Onkologii


If your research field is/are related to Biochemistry (medical) (Q4); Cancer Research (Q4); Genetics (clinical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Chemie in Unserer Zeit journal 20029 Wiley-VCH Verlag 24 0.21
Studies in American Indian Literatures journal 22819 University of Nebraska Press 11 0.11
Journal of Nucleic Acids journal 8799 Hindawi Publishing Corporation 33 2.50
Engineering Review journal 21031 University of Rijeka 12 0.35
Food and Bioproducts Processing journal 5449 Institution of Chemical Engineers 80 5.00
Journal of Applied Psychology journal 168 American Psychological Association 306 10.71
Journal of Molecular Evolution journal 6731 Springer New York 128 2.90
Obstetrics and Gynecology Clinics of North America journal 1255 W.B. Saunders Ltd 64 2.56
Botanica Marina journal 11358 Walter de Gruyter GmbH 60 1.88
PeerJ journal 6102 PeerJ Inc. 83 3.01

Check complete list





Top Journals/Conferences in Biochemistry (medical)

Chem
Elsevier Inc. | United States

Journal of Clinical Endocrinology and Metabolism
Endocrine Society | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Translational Research
Mosby Inc. | United States

Critical Reviews in Clinical Laboratory Sciences
Informa Healthcare | United Kingdom

Clinical Chemistry
American Association for Clinical Chemistry Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Chemical Record
John Wiley and Sons Inc. | United States

Journal of Atherosclerosis and Thrombosis
Japan Atherosclerosis Society | Japan

Non-coding RNA Research
KeAi Publishing Communications Ltd. | China

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

See All

Top Journals/Conferences in Genetics (clinical)

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Genome Research
Cold Spring Harbor Laboratory Press | United States

American Journal of Human Genetics
Cell Press | United States

Annual Review of Genomics and Human Genetics
Annual Reviews Inc. | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

PLoS Genetics
Public Library of Science | United States

Genetics in Medicine
Lippincott Williams and Wilkins Ltd. | United States

Human Molecular Genetics
Oxford University Press | United Kingdom

Circulation. Genomic and precision medicine
Lippincott Williams and Wilkins Ltd. | United States

npj Genomic Medicine
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Theranostics
Ivyspring International Publisher | Australia

PLoS Neglected Tropical Diseases
Public Library of Science | United States

Acta Pharmaceutica Sinica B
Elsevier BV | Netherlands

Handbook of Experimental Pharmacology
Springer Heidelberg | Germany

Nanotheranostics
Ivyspring International Publishers | Australia

Clinical and Translational Science
Wiley-Blackwell Publishing Ltd | United Kingdom

Life Sciences
Elsevier Inc. | United States

F1000Research
| United Kingdom

Drug Metabolism Reviews
Informa Healthcare | United States

Expert Review of Clinical Pharmacology
Taylor and Francis Ltd. | United Kingdom

See All